The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
IU School of Medicine
With more than 60 academic departments and specialty divisions across nine campuses and strong clinical partnerships with Indiana’s most advanced hospitals and physician networks, Indiana University School of Medicine is continuously advancing its miss...
An Indiana University School of Medicine researcher is among a select group of scientists whom the National Eye Institute has funded to develop models to gauge the survival and integration of regenerated cells to treat degenerative and blinding diseases.
The world’s most comprehensive concussion study is being expanded with a boost of nearly $42.65 million in new funding, aimed at following athletes for a decade after injury—examining the impacts of head injuries after graduation.
Two Indiana University Melvin and Bren Simon Comprehensive Cancer Center researchers are now part of a prestigious Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute.
Indiana University School of Medicine has appointed Kun Huang, PhD, as chair of the Department of Biostatistics and Health Data Science, effective October 1, 2021. Huang brings a tremendous amount of research, education and leadership experience to the role. He currently serves as vice chair for data science and professor with the department.
When the Food and Drug Administration approved the use of the drug aducanumab to treat Alzheimer’s disease in early June, leaders in neurodegeneration research quickly created an expert panel to issue guidance to physicians on how to best administer the drug.
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified how restoring a missing molecule in pancreatic fibrosis could help deliver treatments to cancer cells.
A new $11.2 million grant coordinated by the Indiana University School of Medicine from the National Institute on Aging (NIA) will support an international collaboration on multiethnic genomic analysis and advanced brain imaging and other biomarkers for early detection of Alzheimer’s disease.